Geode Capital Management’s TriSalus Life Sciences TLSI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.48M | Buy |
455,051
+235,627
| +107% | +$1.28M | ﹤0.01% | 3069 |
|
|
2025
Q1 | $1.21M | Buy |
219,424
+15,287
| +7% | +$84.4K | ﹤0.01% | 3239 |
|
|
2024
Q4 | $1.02M | Buy |
204,137
+3,710
| +2% | +$18.6K | ﹤0.01% | 3371 |
|
|
2024
Q3 | $924K | Buy |
200,427
+62,542
| +45% | +$288K | ﹤0.01% | 3382 |
|
|
2024
Q2 | $761K | Buy |
137,885
+3,786
| +3% | +$20.9K | ﹤0.01% | 3411 |
|
|
2024
Q1 | $1.31M | Buy |
134,099
+8,337
| +7% | +$81.3K | ﹤0.01% | 3260 |
|
|
2023
Q4 | $1.06M | Buy |
125,762
+108,523
| +630% | +$917K | ﹤0.01% | 3337 |
|
|
2023
Q3 | $88.3K | Hold |
17,239
| – | – | ﹤0.01% | 4288 |
|
|
2023
Q2 | $181K | Hold |
17,239
| – | – | ﹤0.01% | 4087 |
|
|
2023
Q1 | $176K | Hold |
17,239
| – | – | ﹤0.01% | 4115 |
|
|
2022
Q4 | $173K | Hold |
17,239
| – | – | ﹤0.01% | 4175 |
|
|
2022
Q3 | $171K | Hold |
17,239
| – | – | ﹤0.01% | 4298 |
|
|
2022
Q2 | $169K | Hold |
17,239
| – | – | ﹤0.01% | 4369 |
|
|
2022
Q1 | $168K | Sell |
17,239
-1,367
| -7% | -$13.3K | ﹤0.01% | 4458 |
|
|
2021
Q4 | $183K | Hold |
18,606
| – | – | ﹤0.01% | 4516 |
|
|
2021
Q3 | $184K | Hold |
18,606
| – | – | ﹤0.01% | 4484 |
|
|
2021
Q2 | $181K | Buy |
18,606
+1,341
| +8% | +$13K | ﹤0.01% | 4376 |
|
|
2021
Q1 | $166K | Buy |
+17,265
| New | +$166K | ﹤0.01% | 4172 |
|